Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Supratentorial Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Postoperative Hemorrhage 1Oropharyngeal Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia 1Hodgkin Disease 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Anus Neoplasms 1Agnosia 1

Interventions

Cisplatin 32Radiotherapy, Intensity-Modulated 21Magnetic Resonance Spectroscopy 21Radiotherapy 16Specimen Handling 15Radiation 14Carboplatin 14pembrolizumab 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Paclitaxel 8Chemoradiotherapy 7Biopsy 7Taxes 6Surveys and Questionnaires 6Cetuximab 6Nivolumab 5Surgical Procedures, Operative 4Observation 4Fluorodeoxyglucose F18 4Drug Therapy 4Docetaxel 4durvalumab 3(225)Ac-DOTA-c(RGDyK) 3toripalimab 2cemiplimab 2atezolizumab 2aldesleukin 2X-Rays 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Epinephrine × 1 year × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡